Sei Investments Co. Sells 4,026 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Sei Investments Co. lessened its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 21.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,889 shares of the company's stock after selling 4,026 shares during the period. Sei Investments Co. owned approximately 0.08% of Addus HomeCare worth $1,866,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. JPMorgan Chase & Co. boosted its stake in Addus HomeCare by 10.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 183,198 shares of the company's stock worth $24,371,000 after purchasing an additional 16,997 shares during the period. Principal Financial Group Inc. grew its holdings in shares of Addus HomeCare by 17.5% during the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company's stock worth $67,293,000 after buying an additional 75,409 shares in the last quarter. Cherry Creek Investment Advisors Inc. acquired a new stake in Addus HomeCare in the 4th quarter valued at approximately $340,000. Barclays PLC lifted its stake in Addus HomeCare by 204.8% in the 3rd quarter. Barclays PLC now owns 43,470 shares of the company's stock valued at $5,783,000 after acquiring an additional 29,207 shares in the last quarter. Finally, Amundi boosted its position in Addus HomeCare by 185.9% during the 4th quarter. Amundi now owns 9,008 shares of the company's stock worth $1,139,000 after acquiring an additional 5,857 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Analysts Set New Price Targets

A number of analysts have recently issued reports on ADUS shares. Oppenheimer boosted their price objective on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. StockNews.com cut shares of Addus HomeCare from a "buy" rating to a "hold" rating in a research report on Wednesday, February 26th. Citizens Jmp upgraded Addus HomeCare to a "strong-buy" rating in a report on Monday, December 16th. Stephens reiterated an "overweight" rating and set a $142.00 target price on shares of Addus HomeCare in a report on Wednesday, March 12th. Finally, JMP Securities restated a "market outperform" rating and issued a $150.00 price target on shares of Addus HomeCare in a research note on Thursday. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, seven have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $132.78.

Addus HomeCare Price Performance

Addus HomeCare stock traded up $0.77 during mid-day trading on Thursday, hitting $101.77. 236,527 shares of the company's stock traded hands, compared to its average volume of 163,107. The firm has a 50 day simple moving average of $101.60 and a two-hundred day simple moving average of $118.29. Addus HomeCare Co. has a fifty-two week low of $87.88 and a fifty-two week high of $136.72. The stock has a market cap of $1.85 billion, a price-to-earnings ratio of 23.29, a P/E/G ratio of 1.41 and a beta of 0.93.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its earnings results on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.35 by ($0.09). The company had revenue of $297.14 million for the quarter, compared to analyst estimates of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. On average, research analysts anticipate that Addus HomeCare Co. will post 4.59 earnings per share for the current fiscal year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.